Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081512 | SCV000113443 | benign | not specified | 2013-09-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000230285 | SCV000171074 | benign | not provided | 2018-11-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27470939, 23708187, 26993267, 25728773, 27125728) |
Genetic Services Laboratory, |
RCV000081512 | SCV000194740 | benign | not specified | 2013-07-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001081799 | SCV000289711 | benign | Developmental and epileptic encephalopathy, 12 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000081512 | SCV000540071 | likely benign | not specified | 2016-06-02 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: reported in 1 homozygous individual with epileptic encephalopathy by Carvill, 2013. However, the frequency in ExAC (0.75% in ExAC) and the presence of 5 homozygotes in ExAC argue against a pathogenic role for this variant |
Genome Diagnostics Laboratory, |
RCV000625160 | SCV000743938 | benign | Microcephaly, seizures, and developmental delay | 2014-10-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625160 | SCV000745400 | benign | Microcephaly, seizures, and developmental delay | 2017-05-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311645 | SCV000846973 | benign | Inborn genetic diseases | 2017-05-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000230285 | SCV001135140 | benign | not provided | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000625160 | SCV001291586 | benign | Microcephaly, seizures, and developmental delay | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Ce |
RCV000230285 | SCV002543964 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | PNKP: BS1, BS2 |